Hepatocellular Carcinoma Symptoms: Early Detection and Risk Factors in India
Key Facts at a Glance
- Sample Required: Blood sample (for AFP, liver function tests) or imaging (ultrasound, CT/MRI) – no specific sample for symptoms.
- Fasting Rules: Fasting for 8–12 hours may be required for accurate liver function tests.
- Turnaround Time (TAT): Blood tests: 24–48 hours; imaging: same day; biopsy: 3–5 days.
- Base Cost: [Insert Current 2026 Price] – varies by test and location.
Understanding Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy, accounting for approximately 75–85% of liver cancer cases. In India, HCC is the third leading cause of cancer-related mortality, with an estimated 1.2 lakh new cases annually. The disease often develops silently, with symptoms appearing only in advanced stages, underscoring the need for proactive screening in high-risk populations.
Risk Factors and Pathogenesis
HCC arises from chronic liver injury and regeneration, leading to genetic mutations and uncontrolled cell proliferation. Key risk factors in India include:
- Chronic Hepatitis B and C: Persistent viral infections are the leading cause of HCC in India, responsible for ~70% of cases.
- Cirrhosis: Liver scarring from any cause (alcohol, viral, metabolic) increases HCC risk 5–30 fold.
- Non-alcoholic Fatty Liver Disease (NAFLD): Rising due to obesity and diabetes, NAFLD can progress to cirrhosis and HCC even without viral infection.
- Aflatoxin Exposure: Contaminated food (stored grains, peanuts) is a co-factor in some regions.
- Genetic Syndromes: Hereditary hemochromatosis, Wilson disease, and alpha-1 antitrypsin deficiency predispose to HCC.
Clinical Presentation: Symptom Timeline
Early HCC is often asymptomatic. As the tumor grows or liver function deteriorates, symptoms emerge. The following table outlines the typical progression:
| Stage | Common Symptoms | Signs on Examination |
|---|---|---|
| Early (Localized) | Often none; mild fatigue, right upper quadrant discomfort | Hepatomegaly, splenomegaly (if cirrhosis) |
| Intermediate (Multifocal) | Unexplained weight loss, loss of appetite, abdominal swelling (ascites) | Jaundice, spider angiomas, palmar erythema |
| Advanced (Metastatic) | Severe pain, nausea, vomiting, easy bruising/bleeding, confusion (hepatic encephalopathy) | Ascites, peripheral edema, asterixis |
It is crucial to note that these symptoms are non-specific and may be caused by other liver conditions. Persistent symptoms warrant immediate medical evaluation.
Diagnostic Modalities and Screening
Early detection significantly improves survival. Screening is recommended for high-risk individuals (cirrhosis, chronic hepatitis B/C, NAFLD) every 6 months using:
- Blood Tests: Alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) levels.
- Imaging: Ultrasound (USG) is the first-line; contrast-enhanced CT or MRI for confirmation.
- Biopsy: Percutaneous or image-guided biopsy for histopathological confirmation when imaging is inconclusive.
For hereditary cancer syndromes (e.g., Lynch syndrome, familial adenomatous polyposis), genetic testing using Next-Generation Sequencing (NGS) may identify germline mutations that increase HCC risk. DNA Labs India offers comprehensive genomic panels for such evaluations.
| Test Type | Purpose | Frequency |
|---|---|---|
| Screening (High-risk) | AFP + USG every 6 months | Every 6 months |
| Diagnostic (Suspicious) | CT/MRI with contrast, biopsy if needed | As clinically indicated |
| Genetic (Hereditary) | NGS panel for cancer predisposition genes | One-time |
Prognosis and Survival Rates
Survival depends on stage at diagnosis. Localized HCC (stage I) has a 5-year survival of 60–70% with curative treatments (resection, ablation, transplant). Advanced HCC has a median survival of 6–12 months without treatment. Early detection through regular screening is the most effective strategy to improve outcomes.
Preventive Strategies and Lifestyle Modifications
- Hepatitis B Vaccination: Universal immunization reduces HCC risk by 80%.
- Antiviral Therapy: For chronic hepatitis B/C, antiviral treatment can halt disease progression.
- Alcohol Moderation: Limit or avoid alcohol to prevent cirrhosis.
- Weight Management: Control obesity and diabetes to prevent NAFLD.
- Dietary Safety: Avoid aflatoxin-contaminated foods (proper storage of grains).
When to Seek Medical Attention
If you experience any of the following for more than two weeks, consult a physician immediately:
- Unexplained weight loss or loss of appetite
- Persistent abdominal pain or swelling
- Jaundice (yellowing of skin/eyes)
- Easy bruising or bleeding
- Severe fatigue or weakness
Early diagnosis saves lives. Do not delay.
Written by: Dr. Ananya Sharma, MBBS, MD (Internal Medicine)
Medically Reviewed by: Dr. Rajesh Kumar, DM (Gastroenterology)
Last Updated: March 2026